Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-01 21:35:02 - browse：96

Closeup of a human brain affected by Alzheimer's disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. — A brain affected by Alzheimer's disease, at the Museum of Neuroanatomy at the University at Buffalo. David Duprey/AP

Investigators on Wednesday released the first detailed case report about a patient who died after receiving lecanemab, providing a new glimpse into safety concerns surrounding the closely watched experimental Alzheimer’s drug.

An unpublished version of the report was previously written about by Science in November, one of three deaths from the lecanemab trials revealed by Science and STAT. But the published version, in the New England Journal of Medicine, will allow doctors to evaluate the case as they consider whether and how to use a treatment that could be approved by the FDA as soon as this week.

This “will have greater impact on clinicians because it is peer-reviewed and published in the New England Journal,” said Lon Schneider, an Alzheimer’s expert at University of Southern California, who was not affiliated with the work.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： CRISPR technology availability, affordability needs to be expanded

hotspot

WSS

Diabetes management: Digital health tools fall short, study says

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

6 surprising facts about sugar

Bird flu surveillance in wastewater gets boost from consortium

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Addressing health care workers' trauma can help fight burnout

focus

Wikipedia

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Supreme Court strikes down use of affirmative action

Bring on the sabbaticals for nurses

Walensky prepares to leave CDC — and Congress — behind

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Dobbs anniversary: the lost opportunity of abortion as health care

As a primary care physician, here's how I hope to partner with AI

Supreme Court strikes down use of affirmative action

Biogen joins immunology wave with $1.15 billion acquisition of HI

hotspot

Cancer, immunology, HIV research ensnared in fetal tissue politics

'Patient friction coefficient' can gauge a clinical trial's patient burden

U.K. officials, researchers try to ease path for bespoke genetic treatments

Making the case for fair compensation in clinical trials

Pregnancy ages women, but effects reverse after delivery

For longer

hotspot

leisure time

knowledge

leisure time